HIMS Common Stock · Transaction Feb 3, 2026 · Filed Mar 9, 2026 · Amount pending receipt enrichment
Hims & Hers Health Inc
Veridion Score
BETAHIGH CONF · 6/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is HIMS moving today?
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
HIMS overview
Related filings and maps
Congress activity in HIMS
Hims & Hers Health, Inc. Class A Common Stock · Transaction Aug 4, 2025 · Filed Sep 12, 2025 · $1,001 to $15,000
HIMS contract awards, year to date.
Public federal awards linked to this ticker.
HIMS lobbying filings, year to date.
Registered lobbying filings matched to Hims & Hers Health Inc.